Burden of Influenza and Respiratory Syncytial Viru... - BV FAPESP
Busca avançada
Ano de início
Entree


Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study

Texto completo
Autor(es):
Mostrar menos -
da Costa, Vivaldo Gomes ; Gomes, Ana Julia Chaves ; Bittar, Cintia ; Geraldini, Dayla Bott ; da Conceicao, Pamela Joyce Previdelli ; Cabral, agata Silva ; Carvalho, Tamara ; Biselli, Joice Matos ; Provazzi, Paola Jocelan Scarin ; Campos, Guilherme Rodrigues Fernandes ; Sanches, Paulo Ricardo da Silva ; Costa, Paulo Inacio ; Nogueira, Mauricio Lacerda ; Araujo Jr, Joao Pessoa ; Spilki, Fernando Rosado ; Calmon, Marilia Freitas ; Rahal, Paula
Número total de Autores: 17
Tipo de documento: Artigo Científico
Fonte: Viruses-Basel; v. 15, n. 3, p. 16-pg., 2023-03-01.
Resumo

Non-SARS-CoV-2 respiratory viral infections, such as influenza virus (FluV) and human respiratory syncytial virus (RSV), have contributed considerably to the burden of infectious diseases in the non-COVID-19 era. While the rates of co-infection in SARS-CoV-2-positive group (SCPG) patients have been determined, the burden of other respiratory viruses in the SARS-CoV-2-negative group (SCNG) remains unclear. Here, we conducted a cross-sectional study (Sao Jose do Rio Preto county, Brazil), and we collected our data using a meta-analysis to evaluate the pooled prevalence of FluV and RSV among SCNG patients. Out of the 901 patients suspected of COVID-19, our molecular results showed positivity of FluV and RSV in the SCNG was 2% (15/733) and 0.27% (2/733), respectively. Co-infection with SARS-CoV-2 and FluV, or RSV, was identified in 1.7% of the patients (3/168). Following our meta-analysis, 28 studies were selected (n = 114,318 suspected COVID-19 patients), with a pooled prevalence of 4% (95% CI: 3-6) for FluV and 2% (95% CI: 1-3) for RSV among SCNG patients were observed. Interestingly, FluV positivity in the SCNG was four times higher (OR = 4, 95% CI: 3.6-5.4, p < 0.01) than in the SCPG. Similarly, RSV positivity was significantly associated with SCNG patients (OR = 2.9, 95% CI: 2-4, p < 0.01). For subgroup analysis, cold-like symptoms, including fever, cough, sore throat, headache, myalgia, diarrhea, and nausea/vomiting, were positively associated (p < 0.05) with the SCPG. In conclusion, these results show that the pooled prevalence of FluV and RSV were significantly higher in the SCNG than in the SCPG during the early phase of the COVID-19 pandemic. (AU)

Processo FAPESP: 20/07419-0 - Estudo clínico e epidemiológico de SARS-CoV-2 em uma coorte prospectiva populacional e hospitalar em São José do Rio Preto, São Paulo, Brasil, durante pandemia de 2020
Beneficiário:Guilherme Rodrigues Fernandes Campos
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 19/18581-6 - Desenvolvimento de kits colorimétricos para quantificação circovírus suíno 2 (PCV-2) e SARS-CoV-2 utilizando nanopartículas de ouro
Beneficiário:João Pessoa Araújo Junior
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 21/00603-3 - Análise do viroma de carrapatos coletados em animais silvestres
Beneficiário:Paula Rahal
Modalidade de apoio: Auxílio à Pesquisa - Regular